Virtus ETF Advisers LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$68,000
-42.4%
25,634
-5.6%
0.03%
-33.3%
Q4 2021$118,000
-20.8%
27,150
-7.5%
0.04%
-31.8%
Q3 2021$149,000
-24.0%
29,358
-5.0%
0.07%
-18.5%
Q2 2021$196,000
-33.3%
30,896
-18.7%
0.08%
-34.7%
Q1 2021$294,000
+20.0%
38,021
+1.8%
0.12%
+21.6%
Q4 2020$245,000
-4.7%
37,343
-3.6%
0.10%
-24.4%
Q3 2020$257,000
-30.0%
38,721
-12.0%
0.14%
-22.4%
Q2 2020$367,000
-4.7%
44,006
-12.4%
0.17%
+10.1%
Q1 2020$385,000
-19.5%
50,226
-12.7%
0.16%
+102.6%
Q4 2019$478,000
+167.0%
57,537
+136.8%
0.08%
+116.7%
Q3 2019$179,000
-37.8%
24,301
-5.3%
0.04%
-41.0%
Q2 2019$288,000
+48.5%
25,654
+41.9%
0.06%
-85.2%
Q1 2019$194,000
-37.0%
18,085
-11.4%
0.41%
+679.2%
Q4 2018$308,000
-11.7%
20,415
+8.3%
0.05%
+47.2%
Q3 2018$349,000
-52.8%
18,850
-41.7%
0.04%
-94.5%
Q2 2018$739,000
-25.5%
32,334
-7.3%
0.65%
-24.2%
Q1 2018$992,000
+192.6%
34,876
+117.2%
0.86%
+102.6%
Q4 2017$339,000
-22.4%
16,059
-33.3%
0.42%
+620.3%
Q3 2017$437,000
+28.9%
24,077
+10.1%
0.06%
+15.7%
Q2 2017$339,00021,8750.05%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders